Pawan Mehan

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 7

Top Topics

Optical Coherence Tomography

Immune Response

Vascular Endothelial Growth Factor

Top Venues

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Anette C Karle, Matthias B Wrobel, Stephan Koepke, Michael Gutknecht, Sascha Gottlieb, Brigitte Christen, Tina Rubic-Schneider, Ingrid Pruimboom-Brees, Xavier Charles Leber, Meike Scharenberg, Benjamin Maciejewski, Oliver C Turner, Chandrassegar Saravanan, François Huet, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Jeffrey D Kearns, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events. Science translational medicine 15 (681) (2023)
Jeffrey D Kearns, Paul Wassmann, Ufuk Olgac, Marie Fichter, Brigitte Christen, Tina Rubic-Schneider, Stephan Koepke, Benjamin Cochin de Billy, David Ledieu, Cedric Andre, Stuart Hawtin, Benoit Fischer, Francesca Moretti, Christian Hug, Alexander Bepperling, Barbara Brannetti, Celia Mendez-Garcia, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees, Anette C Karle
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab. Science translational medicine 15 (681) (2023)
Anette C Karle, Matthias B Wrobel, Stephan Koepke, Michael Gutknecht, Sascha Gottlieb, Brigitte Christen, Tina Rubic-Schneider, Ingrid Pruimboom-Brees, Xavier Charles Leber, Meike Scharenberg, Benjamin Maciejewski, Oliver C Turner, Chandrassegar Saravanan, François Huet, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Jeffrey D Kearns, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events. Science translational medicine 15 (681) (2023)
Jeffrey D Kearns, Paul Wassmann, Ufuk Olgac, Marie Fichter, Brigitte Christen, Tina Rubic-Schneider, Stephan Koepke, Benjamin Cochin de Billy, David Ledieu, Cedric Andre, Stuart Hawtin, Benoit Fischer, Francesca Moretti, Christian Hug, Alexander Bepperling, Barbara Brannetti, Celia Mendez-Garcia, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees, Anette C Karle
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab. Science translational medicine 15 (681) (2023)
Jeffrey D Kearns, Paul Wassmann, Ufuk Olgac, Marie Fichter, Brigitte Christen, Tina Rubic-Schneider, Stephan Koepke, Benjamin Cochin de Billy, David Ledieu, Cedric Andre, Stuart Hawtin, Benoit Fischer, Francesca Moretti, Christian Hug, Alexander Bepperling, Barbara Brannetti, Celia Mendez-Garcia, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees, Anette C Karle
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab. Science translational medicine 15 (681) (2023)
Anette C Karle, Matthias B Wrobel, Stephan Koepke, Michael Gutknecht, Sascha Gottlieb, Brigitte Christen, Tina Rubic-Schneider, Ingrid Pruimboom-Brees, Xavier Charles Leber, Meike Scharenberg, Benjamin Maciejewski, Oliver C Turner, Chandrassegar Saravanan, François Huet, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Jeffrey D Kearns, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events. Science translational medicine 15 (681) (2023)
Anette C Karle, Matthias B Wrobel, Stephan Koepke, Michael Gutknecht, Sascha Gottlieb, Brigitte Christen, Tina Rubic-Schneider, Ingrid Pruimboom-Brees, Xavier Charles Leber, Meike Scharenberg, Benjamin Maciejewski, Oliver C Turner, Chandrassegar Saravanan, François Huet, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Jeffrey D Kearns, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events. Science translational medicine 15 (681) (2023)